Join us on May 23rd for the Annual Food Allergy Fund Summit in New York City highlighting the latest advancements and cutting-edge developments in food allergy research and innovation in 2024.
Click here to see the Speakers
Click here to see the Agenda
8:30 a.m. — 9 a.m.~ Registration
9:00 a.m. ~ Welcome Remarks: Food Allergy Fund Mission and Impact
Ilana Golant, Founder & CEO, Food Allergy Fund
9:15 a.m. ~ The Rise & Prevalence of Food Allergies: A Growing Epidemic
Dr. Ruchi Gupta, Director, Institute for Public Health & Medicine;
Center for Food Allergy Research & Asthma, Northwestern University
9:30 a.m. ~ Key Innovations: Discussion with Novel Therapeutic Companies CEOs
Moderator, Dr. Hugh Sampson, FAF Scientific Advisor
IgGenix, Dr. Jessica Grossman, CEO
Siolta Therapeutics, Dr. Nikole Kimes, Founder & CEO
ATANIS Biotech, Dr. Jean-Pierre Kinet, Co-Founder & CEO
10:15 a.m. — 10:30 a.m. ~ Networking Break
10:30 a.m. ~ Food Allergy Fund Research Roadmap Launch & Discussion
Moderator, Dr. Richard Insel, FAF Scientific Advisor
Dr. Stephanie Eisenbarth, Chief, Allergy & Immunology, Northwestern
Dr. Rima Rachid, Co-Director, Food Allergy Program, Boston Children’s Hospital
Dr. Marc Rothenberg, Director, Allergy & Immunology, Cincinnati Children’s Hospital
11:15 a.m. ~ Keynote: The Power of Repurposing Drugs for Food Allergy
Dr. Grant W. Mitchell
Co-Founder & CEO, Every Cure
11:30 a.m. ~ FAF Repurposing Challenge Grant Recipient Award Presentation
11:45 a.m. ~ Keynote: National Institutes of Health (NIH) Research Briefing
Dr. Alkis Togias
Chief, Allergy, Asthma & Airway Biology Branch
Division of Allergy, Immunology & Transplantation
National Institute of Allergy & Infectious Diseases (NIAID), NIH
12:00 p.m. ~ Networking Lunch
1:00 p.m. ~ Key Innovations: Novel Platforms & Technology Companies CEOs
Moderator, Bunny Ellerin, Co-Founder & CEO Digital Health New York
Anjo.ai, Tal Golan, Co-Founder & CEO
Intrommune Therapeutics, Michael Nelson, CEO
Pirouette Medical, Connor Cullinane, President & CEO
1:30 p.m. ~ The Importance of Biomarkers
Moderator, Thomas Vollmers, Founding Member, Biomarker Alliance
Dr. David Hill, Allergy & Immunology, Children’s Hospital of Philadelphia (CHOP)
Dr. Ronald Rabin, Chief, Lab of Immunobiochemistry, FDA
Dr. Erik Wambre, Director, Translational & Clinical Immunology, Mount Sinai
2:15 p.m. ~ Food-Triggered Diseases: Paving the Way for Change
Moderator: Ilana Golant, Founder & CEO, Food Allergy Fund
Korey Capozza, Founder & Executive Director, Global Parents for Eczema Research
Sharon Forsyth, Founder & Executive Director, Alpha-Gal Alliance
Fallon Schultz, Founder & CEO, IFPIES
2:45 p.m. ~ Closing Remarks & Networking Session
9:00 a.m. ~ Welcome Remarks: Food Allergy Fund Mission and Impact
Ilana Golant, Founder & CEO, Food Allergy Fund
9:15 a.m. ~ The Rise & Prevalence of Food Allergies: A Growing Epidemic
Dr. Ruchi Gupta, Director, Institute for Public Health & Medicine;
Center for Food Allergy Research & Asthma, Northwestern University
9:30 a.m. ~ Key Innovations: Discussion with Novel Therapeutic Companies CEOs
Moderator, Dr. Hugh Sampson, FAF Scientific Advisor
IgGenix, Dr. Jessica Grossman, CEO
Siolta Therapeutics, Dr. Nikole Kimes, Founder & CEO
ATANIS Biotech, Dr. Jean-Pierre Kinet, Co-Founder & CEO
10:15 a.m. — 10:30 a.m. ~ Networking Break
10:30 a.m. ~ Food Allergy Fund Research Roadmap Launch & Discussion
Moderator, Dr. Richard Insel, FAF Scientific Advisor
Dr. Stephanie Eisenbarth, Chief, Allergy & Immunology, Northwestern
Dr. Rima Rachid, Co-Director, Food Allergy Program, Boston Children’s Hospital
Dr. Marc Rothenberg, Director, Allergy & Immunology, Cincinnati Children’s Hospital
11:15 a.m. ~ Keynote: The Power of Repurposing Drugs for Food Allergy
Dr. Grant W. Mitchell
Co-Founder & CEO, Every Cure
11:30 a.m. ~ FAF Repurposing Challenge Grant Recipient Award Presentation
11:45 a.m. ~ Keynote: National Institutes of Health (NIH) Research Briefing
Dr. Alkis Togias
Chief, Allergy, Asthma & Airway Biology Branch
Division of Allergy, Immunology & Transplantation
National Institute of Allergy & Infectious Diseases (NIAID), NIH
12:00 p.m. ~ Networking Lunch
1:00 p.m. ~ Key Innovations: Novel Platforms & Technology Companies CEOs
Moderator, Bunny Ellerin, Co-Founder & CEO Digital Health New York
Anjo.ai, Tal Golan, Co-Founder & CEO
Intrommune Therapeutics, Michael Nelson, CEO
Pirouette Medical, Connor Cullinane, President & CEO
1:30 p.m. ~ The Importance of Biomarkers
Moderator, Thomas Vollmers, Founding Member, Biomarker Alliance
Dr. David Hill, Allergy & Immunology, Children’s Hospital of Philadelphia (CHOP)
Dr. Ronald Rabin, Chief, Lab of Immunobiochemistry, FDA
Dr. Erik Wambre, Director, Translational & Clinical Immunology, Mount Sinai
2:15 p.m. ~ Food-Triggered Diseases: Paving the Way for Change
Moderator: Ilana Golant, Founder & CEO, Food Allergy Fund
Korey Capozza, Founder & Executive Director, Global Parents for Eczema Research
Sharon Forsyth, Founder & Executive Director, Alpha-Gal Alliance
Fallon Schultz, Founder & CEO, IFPIES
2:45 p.m. ~ Closing Remarks & Networking Session